Singh vs Singh: Malvinder accuses brother Shivinder of physical assault

fortis, fortis healthcare, Malvinder singh, Shivinder singh, singh brothers, Daiichi Sankyo, ranbaxy, pharmaceuticals, pharma company, drugs, india news, latest newsThe incident happened at their Hanuman Road
office in New Delhi, on Thursday evening. (Reuters)

The differences between Singh brothers, former promoters of
healthcare major Fortis Healthcare Limited, reached a new level
after elder brother Malvinder Singh alleged that his younger
brother Shivinder Singh assaulted him, according to several
media reports. The incident happened at their Hanuman Road
office, New Delhi, on Thursday evening.

“Today is December 5, 2018. A little after 6 pm. Shivinder
Mohan Singh assaulted me, he physically hit me. He hurt me. He
injured me. He broke the button. He bruised me…kept threatening
me and refused to budge until the team here came together and
separated him from me,” said Malvinder Singh in a half a
minute video, while showing his bruises.

Shivinder Singh, however, refuted the allegation, calling it
‘fake’ and a ‘lie’.

Also Read: SEBI asks
Malvinder Singh, Shivinder Singh, 8 other entities to pay Rs
403 cr back to Fortis

Malvinder Mohan Singh and Shinvder Mohan Singh have been not on
talking terms for months now. The differences between the
two brothers have been widening since they lost control over
family firms Religare Enterprises and Fortis Healthcare.

Read More: The
billionaire brothers and a Guru: How Shivinder, Malvinder Singh
family burned through $2 billion

They, however, come to office and staff has been reporting
to both of them as they hold an equal stakeholding in the group
holding firm RHC Holding. Oscar Investments, which is at
Hanuman road in New Delhi, is one of the investment firms
jointly owned by brothers.

In September this year, Shivinder Singh formally parted ways
from his elder brother Malvinder Singh. He also blamed
Malvinder Singh and Sunil Godhwani, former CMD of Religare
Enterprises, for the group’s troubles, while accusing the elder
brother of using his position to extract money from Religare
and Fortis.

The two brothers now owe $500 billion to Japan’s Daiichi Sankyo
over fraud allegations in relation to the 2008 sale of
drugmaker Ranbaxy Labs. The Serious Fraud Investigations Office
(SFIO) is probing the irregularities in Fortis Healthcare.

Get live Stock Prices from BSE and NSE and latest
NAV, portfolio of Mutual Funds, calculate your tax by
Income Tax Calculator, know market’s
Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *